Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K (including Exhibit 99.1 ) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as a
of this Current Report on Form 8-K (including Exhibit 99.2) shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to
. Other Events On January 9, 2026, the Company announced preliminary unaudited net revenues from global sales of IMCIVREE® (setmelanotide) of approximately $57
. Financial Statements and Exhibits. (d) Exhibits The following Exhibits 99.1 and 99.2 relate to Items 2.02 and 7.01, respectively and shall be deemed to be fur